INMB stock forecast
Our latest prediction for Inmune Bio, Inc.'s stock price was made on the Jan. 27, 2020 when the stock price was at 4.82$.
In the short term (2weeks), INMB's stock price should underperform the market by -3.30%. During that period the price should oscillate between -12.57% and +12.46%.
In the medium term (3months), INMB's stock price should underperform the market by -4.77%. During that period the price should oscillate between -43.46% and +32.26%.Get email alerts
About Inmune Bio, Inc.
Inmune Bio, Inc. is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. Its products include INKMUNE and INB03. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.67$ per share.
The book value per share is 1.70$
Three months stock forecastJan. 27, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|